The impact of arthritis and joint pain on individual healthcare expenditures: findings from the Medical Expenditure Panel Survey (MEPS), 2011

Abstract

BackgroundJoint pain, including back pain, and arthritis are common conditions in the United States, affecting more than 100 million individuals and costing upwards of $200 billion each year. Although activity limitations associated with these disorders impose a substantial economic burden, this relationship has not been explored in a large U.S. cohort.MethodsIn this study, we used the Medical Expenditures Panel Survey to investigate whether functional limitations explain the difference in medical expenditures between patients with arthritis and joint pain and those without. We used sequential explanatory linear models to investigate this relationship and accounted for various covariates.ResultsUnadjusted mean expenditures were $10,587 for those with joint pain or arthritis, compared with $3813 for those without. In a fully adjusted model accounting also for functional limitations, those with joint pain or arthritis paid $1638 more than those without, a statistically significant difference.ConclusionsThe growing economic and public health burden of arthritis and joint pain, as well as the corresponding complications of functional, activity, and sensory limitations, calls for an interdisciplinary approach and heightened awareness among providers to identify strategies that meet the needs of high-risk patients in order to prevent and delay disease progression.

“There Are Still a Lot of Things that I Need”: A Qualitative Study Exploring Opportunities to Improve the Health Services of First Nations People with Arthritis seen at an On-reserve Outreach Rheumatology Clinic

“…Improving function, either through enhancing body capacity to perform meaningful activities or through modifying the environment, was a main need perceived by the participants with arthritis in this study. This result aligns with what has been consistently reported in the worldwide literature, which shows that in comparison to the general population, people living with arthritis consistently experience higher rates of disability (29). The narratives from participants with arthritis express how disability is not only a result of losing the body's capacity to accomplish desire activities but also is conditioned by disabling environments that produce unsurmountable demands on their bodies, which limits the completion of meaningful activities and conditions hopelessness, anxiety and isolation.…”

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative

“…Different studies have reported significant economic burden of psoriasis, PsA, and AS in different countries,21–26 including Italy 27,28. The economic and humanistic burden of SpA is closely connected to the functional status in PsA and AS patients, and it is increased by the fact that SpA usually occurs in active young adults 7,29–33. According to a survey performed in 17 out of the 20 regions in Italy, sponsored by the National Association of Rheumatic Patients, half of the patients with SpA reported disability and one third felt that their condition limited their career progression and personal development 34…”

Evaluation of Self-reported Patient Experiences: Insights from Digital Patient Communities in Psoriatic Arthritis

“…These results were not surprising because psoriatic disease is associated with a substantial economic burden, with costs around $135 billion annually in the United States alone 37 . Although data from the NPF indicate that 91% of patients with psoriatic disease have insurance coverage, out-of-pocket costs ranged anywhere from $2500 to $8000 in patients with psoriasis and PsA, with indirect costs accounting for 52% to 72% of total PsA costs 37,38,39,40 . Not surprisingly, increased costs are contributing to undertreatment of patients with psoriatic disease 41 .…”